224 related articles for article (PubMed ID: 17593161)
1. Initial treatment with lansoprazole in young dyspeptic patients with negative urea breath test result: a randomized controlled trial with 12-month follow-up.
Leung WK; Wu JC; Chan FK; Fung SS; Wong VW; Hui AJ; Hung LC; Sung JJ
Am J Gastroenterol; 2007 Jul; 102(7):1483-8. PubMed ID: 17593161
[TBL] [Abstract][Full Text] [Related]
2. A double blind, randomized, placebo-controlled trial of proton pump inhibitor therapy in patients with uninvestigated dyspepsia.
Rabeneck L; Souchek J; Wristers K; Menke T; Ambriz E; Huang I; Wray N
Am J Gastroenterol; 2002 Dec; 97(12):3045-51. PubMed ID: 12492188
[TBL] [Abstract][Full Text] [Related]
3. Absence of symptomatic benefit of lansoprazole, clarithromycin, and amoxicillin triple therapy in eradication of Helicobacter pylori positive, functional (nonulcer) dyspepsia.
Veldhuyzen van Zanten S; Fedorak RN; Lambert J; Cohen L; Vanjaka A
Am J Gastroenterol; 2003 Sep; 98(9):1963-9. PubMed ID: 14499772
[TBL] [Abstract][Full Text] [Related]
4. Influence of anti-ulcer drugs used in Japan on the result of (13)C-urea breath test for the diagnosis of Helicobacter pylori infection.
Murakami K; Sato R; Okimoto T; Watanabe K; Nasu M; Fujioka T; Kodama M; Kagawa J
J Gastroenterol; 2003; 38(10):937-41. PubMed ID: 14614600
[TBL] [Abstract][Full Text] [Related]
5. Proton pump inhibitor or testing for Helicobacter pylori as the first step for patients presenting with dyspepsia? A cluster-randomized trial.
Jarbol DE; Kragstrup J; Stovring H; Havelund T; Schaffalitzky de Muckadell OB
Am J Gastroenterol; 2006 Jun; 101(6):1200-8. PubMed ID: 16771937
[TBL] [Abstract][Full Text] [Related]
6. Empiric treatment with high and standard dose of omeprazole in general practice: two-week randomized placebo-controlled trial and 12-month follow-up of health-care consumption.
Meineche-Schmidt V
Am J Gastroenterol; 2004 Jun; 99(6):1050-8. PubMed ID: 15180724
[TBL] [Abstract][Full Text] [Related]
7. Can the urea breath test for H.pylori replace endoscopy for the assessment of dyspepsia in primary care?
Fraser AG; McIntosh C; Berry S; Moore L
N Z Med J; 1998 Jan; 111(1058):11-4. PubMed ID: 9484427
[TBL] [Abstract][Full Text] [Related]
8. Nurse-led dyspepsia clinic using the urea breath test for Helicobacter pylori.
Fraser A; Williamson S; Lane M; Hollis B
N Z Med J; 2003 Jun; 116(1176):U479. PubMed ID: 12835807
[TBL] [Abstract][Full Text] [Related]
9. Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials.
Peura DA; Kovacs TO; Metz DC; Siepman N; Pilmer BL; Talley NJ
Am J Med; 2004 Jun; 116(11):740-8. PubMed ID: 15144910
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of the natural antioxidant astaxanthin in the treatment of functional dyspepsia in patients with or without Helicobacter pylori infection: A prospective, randomized, double blind, and placebo-controlled study.
Kupcinskas L; Lafolie P; Lignell A; Kiudelis G; Jonaitis L; Adamonis K; Andersen LP; Wadström T
Phytomedicine; 2008 Jun; 15(6-7):391-9. PubMed ID: 18467083
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of and satisfaction with a Helicobacter pylori "test and treat" strategy compared with prompt endoscopy in young Asians with dyspepsia.
Mahadeva S; Chia YC; Vinothini A; Mohazmi M; Goh KL
Gut; 2008 Sep; 57(9):1214-20. PubMed ID: 18441005
[TBL] [Abstract][Full Text] [Related]
12. A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in helicobacter pylori negative, primary care patients with dyspepsia: the CADET-HN Study.
Veldhuyzen van Zanten SJ; Chiba N; Armstrong D; Barkun A; Thomson A; Smyth S; Escobedo S; Lee J; Sinclair P
Am J Gastroenterol; 2005 Jul; 100(7):1477-88. PubMed ID: 15984968
[TBL] [Abstract][Full Text] [Related]
13. Management of heartburn in a large, randomized, community-based study: comparison of four therapeutic strategies.
Howden CW; Henning JM; Huang B; Lukasik N; Freston JW
Am J Gastroenterol; 2001 Jun; 96(6):1704-10. PubMed ID: 11419818
[TBL] [Abstract][Full Text] [Related]
14. [Should we take into account Helicobacter pylori infection in a patient with dyspeptic symptoms?].
Jian R; Coffin B
Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 2):432-9. PubMed ID: 12700500
[TBL] [Abstract][Full Text] [Related]
15. Comparison of a new office-based stool immunoassay and (13)C-UBT in the diagnosis of current Helicobacter pylori infection.
Wu IC; Wang SW; Yang YC; Yu FJ; Kuo CH; Chuang CH; Lee YC; Ke HL; Kuo FC; Chang LL; Wang WM; Jan CM; Wu DC
J Lab Clin Med; 2006 Mar; 147(3):145-9. PubMed ID: 16503245
[TBL] [Abstract][Full Text] [Related]
16. Gastroduodenal lesions and Helicobacter pylori infection in dyspeptic patients with and without chronic renal failure.
Nardone G; Rocco A; Fiorillo M; Del Pezzo M; Autiero G; Cuomo R; Sarnelli G; Lambiase A; Budillon G; Cianciaruso B
Helicobacter; 2005 Feb; 10(1):53-8. PubMed ID: 15691315
[TBL] [Abstract][Full Text] [Related]
17. Celecoxib plus aspirin versus naproxen and lansoprazole plus aspirin: a randomized, double-blind, endoscopic trial.
Goldstein JL; Cryer B; Amer F; Hunt B
Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1167-74. PubMed ID: 17916545
[TBL] [Abstract][Full Text] [Related]
18. Lack of effect of Helicobacter pylori on symptom improvement with a prokinetic medication, cisapride, in patients with non-ulcer dyspepsia.
Gonlachanvit S; Mahachai V; Chaiwatanarat T; Kullavanijaya P
J Med Assoc Thai; 2005 May; 88(5):660-7. PubMed ID: 16149685
[TBL] [Abstract][Full Text] [Related]
19. Esomeprazole 40 mg once a day in patients with functional dyspepsia: the randomized, placebo-controlled "ENTER" trial.
van Zanten SV; Armstrong D; Chiba N; Flook N; White RJ; Chakraborty B; Gasco A
Am J Gastroenterol; 2006 Sep; 101(9):2096-106. PubMed ID: 16817845
[TBL] [Abstract][Full Text] [Related]
20. [Assessment of quality of life in functional dyspepsia. Validation of a questionnaire and its use in clinical practice].
Buzás GM
Orv Hetil; 2004 Mar; 145(13):687-92. PubMed ID: 15125319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
